| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |